Zobrazeno 1 - 10
of 16
pro vyhledávání: '"S M, Coutts"'
Publikováno v:
ChemInform. 29
Publikováno v:
Advances in immunology. 70
Advances in defining the target antigen(s) for the autoantibodies in the APS highlight the inadequacies of the current classification of these autoantibodies into anticardiolipin and LA antibodies. The discovery that beta 2GPI is the target antigen f
Autor:
P. D. Smith, C. D. Daykin, S. M. Coutts, E. R. F. Devitt, G. B. Hey, D. I. W. Reynolds, G. D. Bernstein
Publikováno v:
Journal of the Institute of Actuaries. 114:227-325
After reviewing some general issues concerning solvency and the problems associated with establishing the financial strength of a general insurance company using the traditional balance sheet concept, the authors put forward an emerging costs approac
Publikováno v:
The Journal of Immunology. 124:2309-2315
Publikováno v:
Proceedings of the National Academy of Sciences. 73:1164-1168
Kinetic proofreading is a reaction scheme with a structure more complicated than that of Michaelis kinetics, which leads to a proofreading for errors in the recognition of a correct substrate by an enzyme. We have measured the stoichiometry between A
Autor:
S. M. Coutts
Publikováno v:
Journal of the Institute of Actuaries. 111:87-148
This paper is largely based on a Ph.D. thesis (Coutts (1983)) and provides an actuarial approach to the technical aspects of motor insurance premium rating, where equal weights are given to both the practical and statistical elements of the problem.
Autor:
C. D. Daykin, G. D. Bernstein, S. M. Coutts, E. R. F. Devitt, G. B. Hey, D. I. W. Reynolds, P. D. Smith
Publikováno v:
ASTIN Bulletin. 17:85-132
The authors challenge the traditional balance sheet concept of the solvency of a general insurance company and put forward an emerging costs concept, which enables the true nature of the assets and liabilities to be taken into account, including thei
Publikováno v:
International archives of allergy and applied immunology. 70(4)
Nylidrin (RHC 3432-A) has been investigated for its antiallergic activity in three in vitro models. Nylidrin was an effective inhibitor of IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils, and
Publikováno v:
International archives of allergy and applied immunology. 70(4)
Nylidrin hydrochloride has weak beta-adrenergic agonist properties with rat mast cells, and shows synergy with 3-isobutyl-1-methylxanthine (IBMX) in raising intracellular cAMP in purified mast cells; both of these properties can be blocked by dl-prop
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 124(5)